CT’s Protein Sciences arming for bird-flu vaccine

Contributed photo
Contributed photo
Protein Sciences large-scale manufacturing facility in Pearl River, N.Y.

Meriden flu-vaccine maker Protein Sciences says it is ramped up and ready to produce enough quantities of vaccine as necessary to prevent a pandemic from the deadly H7N9 bird flu virus that has taken root in China.

The company claims that in just 100 days, it renovated and outfitted Pfizer Inc.’s former Pearl River, N.Y., facility to produce three lots of antigens for its Flublok brand seasonal anti-flu treatment that won federal approval back in January.

 

Read Full Article Here